G3-C12-1 mg

Description

G3-C12 is a galectin-3 binding peptide, with Kd of 88 nM, and shows anticancer activity. –80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–Cancer-programmed cell death–C74H115N23O23S2—-[1]Kopansky E, et al. Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer. J Drug Target. 2011 Dec;19(10):933-43.–848301-94-0–1758.98–99.44–O=C(N[C@@H](CC(N)=O)C(N[C@@H]([C@H](O)C)C(N1[C@@H](CCC1)C(N[C@@H](CS)C(NCC(N2[C@@H](CCC2)C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC4=CNC=N4)C(N[C@@H](CC(O)=O)C(N[C@@H](CS)C(N5[C@@H](CCC5)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N–Cancer–H2O : ≥ 100 mg/mL–Galectin–Galectin-3–Immunology/Inflammation–Peptides